Industry Outlook and Trend Analysis

The Stereotactic Surgery Devices Market is expected to gain considerable market share by 2025, while registering itself at a significant compound annual growth rate (CAGR) during the forecast period. Different advantages of cutting edge minimally invasive stereotactic surgeries, for example, lower morbidity & mortality, faster recovery, and shorter stays in hospitals, are supporting their implementation. Subsequently, these devices are supplanting customary invasive techniques. Additionally, rising take-up of these devices among patients experiencing arteriovenous contortions, Parkinson’s disease, and epilepsy is evaluated to give a huge push to the market over the coming years. Increment in rate of these conditions has positive effect on the development of the market.

Product Outlook and Trend Analysis

LINAC represented the biggest volume share inferable from high number of adoption and installations. Nonetheless, the CyberKnife section is anticipated to extend at the most astounding CAGR regarding both volume and incentive over the gauge time frame, inferable from its developing fame in emerging countries. High rate of adoption of LINACs is ascribed to its higher viability in treating affected area with high measures of radiation, while keeping up a lower risk of harm to healthy cells. Lessened careful torment is likewise boosting its implementation over ordinary radiotherapies.

Regional Outlook and Trend Analysis

North America ruled the general market in 2017. The pattern is foreseen to proceed over the forecast. The development of the area can be ascribed to developing predominance of cancer, expanding government activities for creating awareness about accessibility of cutting edge treatment modalities, and existence of well-developed healthcare infrastructure. Rapidly creating economies, for example, Mexico, Brazil, and Argentina, in Latin America are assessed to animate the development of the regional market.

Competitive Insights

The major players in the market are Pfizer, AstraZeneca, Teva Pharmaceutical Industries, Novartis, Merck Group, Ferring B.V, Bayer, Bristol-Myers Squibb, Abbott Laboratories and Sanofi. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The Stereotactic Surgery Devices Market is segmented by regions as follows-

By Region


North America


U.S.
Canada
Mexico


Europe

Germany
UK
France
Russia
Italy
Rest of Europe


Asia-Pacific

China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific


South America

Brazil
Argentina
Columbia
Rest of South America


Middle East and Africa

Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA




Some of the key questions answered by the report are:


What was the market size in 2014 and forecast from 2015 to 2025?
What will be the industry market growth from 2015 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?